Elite Health Systems INC
Market Movers (8-K)
Elite Health Systems Inc. announced its Board of Directors has authorized management to explore strategic alternatives, including potential capital raises, asset sales, mergers, or dispositions.
Capital raise
Elite Health Systems Inc. stockholders approved key proposals including director elections, an increase in authorized shares, a new equity plan, and the acquisition of Physician Support Systems, Inc.
Capital raise
Elite Health Systems Inc. announced an agreement to acquire Physician Support Systems, Inc. for 3,158,000 shares of common stock, a transaction involving its CEO and his daughter as major PSS stockholders.
Capital raise
Elite Health Systems' subsidiary, Elite Health Plan, Inc., has executed a contract with CMS to offer Medicare Advantage Plans, with member onboarding expected to begin in October 2025.
Elite Health Systems Inc. announced the appointment of Dr. Haranath Policherla as a non-executive director and Ken Minor as Chief Financial Officer, effective immediately.
Elite Health Systems Inc. has commenced a private placement to raise up to $5 million and entered a non-binding letter of intent to acquire Physician Support Systems, Inc., while its subsidiary Elite Health Plan received conditional CMS approval for its 2026 Medicare Advantage application.
Capital raise
Quarterly Earnings (10-Q)
Elite Health Systems Inc. reported a substantial net loss for the first quarter of 2026, primarily driven by the acquisition of Physician Support Systems (PSS) and the commencement of operations for its Medicare Advantage plans.
Capital raise
Worse than expected
Elite Health Systems Inc. reported a widened net loss in Q3 2025 as it continues to invest heavily in its new Medicare Advantage plan business, with revenue generation expected in January 2026.
Capital raise
Worse than expected
Elite Health Systems Inc. reports continued losses in Q2 2025 as it focuses on establishing Medicare Advantage plans in California and Nevada, securing key regulatory approvals while facing going concern doubts.
Capital raise
10-Q: Elite Health Systems Inc. Reports Q1 2025 Results; Focuses on Medicare Advantage Plan Development
Elite Health Systems Inc. reports a net loss for Q1 2025 as it continues to invest in developing its Medicare Advantage plan, Elite Health.
Worse than expected
Capital raise
Elite Health Systems Inc. reported a net loss for Q3 2024, while making progress in its strategic shift towards establishing a managed care organization.
Worse than expected
Capital raise
U.S. NeuroSurgical Holdings reported a net loss for Q2 2024, while strategically investing in its Elite Health managed care initiative.
Worse than expected
Capital raise
Annual Reports (10-K)
Elite Health Systems Inc. files its 2025 10-K, detailing progress in its Medicare Advantage plan development and the acquisition of Physician Support Systems Inc.
Worse than expected
Capital raise
Elite Health Systems Inc. is concentrating on developing Medicare Advantage plans in California and Nevada, despite reporting a net loss of $2.055 million in 2024 and facing substantial doubt about its ability to continue as a going concern.
Capital raise
Worse than expected
U.S. NeuroSurgical Holdings has filed an amendment to its annual report to correct errors in the auditor's report, with no material impact on the company's financials.
Worse than expected
10-K: U.S. NeuroSurgical Holdings Focuses on Medicare Advantage Plans After Radiological Center Exits
U.S. NeuroSurgical Holdings is shifting its focus to developing Medicare Advantage plans through its Elite Health subsidiaries, while winding down its radiological treatment center operations.
Worse than expected
Capital raise
Insider Trading (Form 4)
Prasad Anjaneya Jeereddi, a Director and CEO of Elite Health Systems Inc., acquired 42,105 shares of common stock.
CEO Prasad Anjaneya Jeereddi acquired 12,000 shares of Elite Health Systems Inc. through Haven Hospital LLC.
Prasad Anjaneya Jeereddi, CEO and Director of Elite Health Systems Inc., reported a transaction involving the acquisition of 1,707 shares of common stock.
Elite Health Systems CEO Prasad Anjaneya Jeereddi increased his indirect beneficial ownership of common stock through two separate purchases in early January 2026.
Elite Health Systems Inc.'s CEO, Director, and 10% owner, Prasad Anjaneya Jeereddi, acquired 1,452,680 shares of common stock at $0.95 per share.
Better than expected
Elite Health Systems Inc. Director Alan Gold acquired 25,000 stock options at an exercise price of $0.95 under the company's 2025 Equity Incentive Plan.
Proxy Statements (Def-14A)
Elite Health Systems seeks stockholder approval for a special meeting to vote on key proposals including a share increase, equity incentive plan, and acquisition of Physician Support Systems, Inc.
Capital raise
Worse than expected
Schedule 13D - Activist Investments
Dr. Prasad Jeereddi, CEO, and Dr. Praveena Jeereddi have significantly increased their beneficial ownership in Elite Health Systems Inc. following the acquisition of Physician Support Systems, Inc.
Schedule 13G - Passive Investments
Allen Holding Inc., Allen & Company Incorporated, and Herbert A. Allen have jointly disclosed a passive 7.6% beneficial ownership stake in Elite Health Systems Inc., totaling 1,578,489 shares.